nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—endogenous depression—Citalopram—alcohol dependence	0.187	0.557	CpDpCtD
Duloxetine—bipolar disorder—Citalopram—alcohol dependence	0.148	0.443	CpDpCtD
Duloxetine—SLC6A3—alcohol dependence	0.119	0.431	CbGaD
Duloxetine—SLC6A4—alcohol dependence	0.0892	0.322	CbGaD
Duloxetine—HTR2A—alcohol dependence	0.0685	0.247	CbGaD
Duloxetine—SLC6A3—Citalopram—alcohol dependence	0.057	0.261	CbGbCtD
Duloxetine—SLC6A4—Citalopram—alcohol dependence	0.0499	0.229	CbGbCtD
Duloxetine—HTR2C—Citalopram—alcohol dependence	0.0417	0.191	CbGbCtD
Duloxetine—SLC6A2—Citalopram—alcohol dependence	0.0417	0.191	CbGbCtD
Duloxetine—CYP1A2—Citalopram—alcohol dependence	0.0152	0.0696	CbGbCtD
Duloxetine—CYP2D6—Citalopram—alcohol dependence	0.0125	0.0574	CbGbCtD
Duloxetine—SLC6A2—locus ceruleus—alcohol dependence	0.00229	0.0788	CbGeAlD
Duloxetine—NPY1R—nerve—alcohol dependence	0.00202	0.0694	CbGeAlD
Duloxetine—HTR2A—locus ceruleus—alcohol dependence	0.00138	0.0474	CbGeAlD
Duloxetine—SLC6A2—autonomic nervous system—alcohol dependence	0.00122	0.0419	CbGeAlD
Duloxetine—HTR2A—cerebellar cortex—alcohol dependence	0.00112	0.0386	CbGeAlD
Duloxetine—SLC6A3—nerve—alcohol dependence	0.000848	0.0292	CbGeAlD
Duloxetine—NPY1R—forebrain—alcohol dependence	0.000835	0.0287	CbGeAlD
Duloxetine—HTR2A—pons—alcohol dependence	0.000793	0.0273	CbGeAlD
Duloxetine—NPY1R—adrenal cortex—alcohol dependence	0.000774	0.0266	CbGeAlD
Duloxetine—HTR2A—autonomic nervous system—alcohol dependence	0.000731	0.0252	CbGeAlD
Duloxetine—NPY1R—pancreas—alcohol dependence	0.000686	0.0236	CbGeAlD
Duloxetine—SLC6A2—nerve—alcohol dependence	0.000684	0.0236	CbGeAlD
Duloxetine—NPY1R—gonad—alcohol dependence	0.000641	0.0221	CbGeAlD
Duloxetine—HTR6—forebrain—alcohol dependence	0.000588	0.0202	CbGeAlD
Duloxetine—NPY1R—blood—alcohol dependence	0.000558	0.0192	CbGeAlD
Duloxetine—NPY1R—endocrine gland—alcohol dependence	0.000484	0.0167	CbGeAlD
Duloxetine—NPY1R—testis—alcohol dependence	0.000462	0.0159	CbGeAlD
Duloxetine—NPY1R—nervous system—alcohol dependence	0.000453	0.0156	CbGeAlD
Duloxetine—NPY1R—liver—alcohol dependence	0.000437	0.015	CbGeAlD
Duloxetine—NPY1R—central nervous system—alcohol dependence	0.000436	0.015	CbGeAlD
Duloxetine—HTR2A—nerve—alcohol dependence	0.000411	0.0142	CbGeAlD
Duloxetine—SLC6A3—brainstem—alcohol dependence	0.000364	0.0125	CbGeAlD
Duloxetine—HTR2C—brainstem—alcohol dependence	0.000352	0.0121	CbGeAlD
Duloxetine—SLC6A3—forebrain—alcohol dependence	0.000351	0.0121	CbGeAlD
Duloxetine—NPY1R—brain—alcohol dependence	0.000346	0.0119	CbGeAlD
Duloxetine—HTR2C—forebrain—alcohol dependence	0.00034	0.0117	CbGeAlD
Duloxetine—SLC6A4—brainstem—alcohol dependence	0.000334	0.0115	CbGeAlD
Duloxetine—SLC6A4—forebrain—alcohol dependence	0.000322	0.0111	CbGeAlD
Duloxetine—HTR6—nervous system—alcohol dependence	0.000319	0.011	CbGeAlD
Duloxetine—HTR6—central nervous system—alcohol dependence	0.000307	0.0106	CbGeAlD
Duloxetine—Protriptyline—SLC6A4—alcohol dependence	0.000306	0.207	CrCbGaD
Duloxetine—SLC6A2—brainstem—alcohol dependence	0.000294	0.0101	CbGeAlD
Duloxetine—SLC6A2—forebrain—alcohol dependence	0.000283	0.00976	CbGeAlD
Duloxetine—HTR6—brain—alcohol dependence	0.000244	0.0084	CbGeAlD
Duloxetine—SLC6A3—midbrain—alcohol dependence	0.000232	0.00799	CbGeAlD
Duloxetine—SLC6A4—digestive system—alcohol dependence	0.000226	0.00778	CbGeAlD
Duloxetine—HTR2C—midbrain—alcohol dependence	0.000224	0.00772	CbGeAlD
Duloxetine—SLC6A2—gonad—alcohol dependence	0.000217	0.00749	CbGeAlD
Duloxetine—SLC6A4—blood—alcohol dependence	0.000215	0.00741	CbGeAlD
Duloxetine—SLC6A4—midbrain—alcohol dependence	0.000213	0.00732	CbGeAlD
Duloxetine—Fluoxetine—SLC6A4—alcohol dependence	0.000209	0.141	CrCbGaD
Duloxetine—Atomoxetine—HTR1B—alcohol dependence	0.000199	0.134	CrCbGaD
Duloxetine—SLC6A3—testis—alcohol dependence	0.000194	0.00669	CbGeAlD
Duloxetine—SLC6A3—nervous system—alcohol dependence	0.000191	0.00657	CbGeAlD
Duloxetine—Propranolol—HTR1B—alcohol dependence	0.000189	0.128	CrCbGaD
Duloxetine—SLC6A4—endocrine gland—alcohol dependence	0.000187	0.00643	CbGeAlD
Duloxetine—HTR2C—nervous system—alcohol dependence	0.000184	0.00635	CbGeAlD
Duloxetine—SLC6A3—central nervous system—alcohol dependence	0.000184	0.00632	CbGeAlD
Duloxetine—SLC6A3—cerebellum—alcohol dependence	0.000179	0.00618	CbGeAlD
Duloxetine—Atomoxetine—SLC6A3—alcohol dependence	0.000179	0.121	CrCbGaD
Duloxetine—HTR2C—central nervous system—alcohol dependence	0.000177	0.00611	CbGeAlD
Duloxetine—HTR2A—brainstem—alcohol dependence	0.000176	0.00608	CbGeAlD
Duloxetine—SLC6A4—nervous system—alcohol dependence	0.000175	0.00602	CbGeAlD
Duloxetine—HTR2A—forebrain—alcohol dependence	0.00017	0.00587	CbGeAlD
Duloxetine—SLC6A4—central nervous system—alcohol dependence	0.000168	0.00579	CbGeAlD
Duloxetine—SLC6A2—endocrine gland—alcohol dependence	0.000164	0.00566	CbGeAlD
Duloxetine—CYP2D6—brainstem—alcohol dependence	0.000161	0.00554	CbGeAlD
Duloxetine—Fluoxetine—HTR2A—alcohol dependence	0.00016	0.109	CrCbGaD
Duloxetine—SLC6A2—testis—alcohol dependence	0.000157	0.0054	CbGeAlD
Duloxetine—CYP2D6—forebrain—alcohol dependence	0.000155	0.00534	CbGeAlD
Duloxetine—SLC6A2—nervous system—alcohol dependence	0.000154	0.0053	CbGeAlD
Duloxetine—CYP1A2—digestive system—alcohol dependence	0.000153	0.00527	CbGeAlD
Duloxetine—SLC6A2—central nervous system—alcohol dependence	0.000148	0.0051	CbGeAlD
Duloxetine—SLC6A3—brain—alcohol dependence	0.000146	0.00502	CbGeAlD
Duloxetine—CYP1A2—blood—alcohol dependence	0.000146	0.00502	CbGeAlD
Duloxetine—HTR2A—cardiovascular system—alcohol dependence	0.000144	0.00496	CbGeAlD
Duloxetine—HTR2C—brain—alcohol dependence	0.000141	0.00485	CbGeAlD
Duloxetine—Atomoxetine—SLC6A4—alcohol dependence	0.000134	0.0907	CrCbGaD
Duloxetine—SLC6A4—brain—alcohol dependence	0.000134	0.0046	CbGeAlD
Duloxetine—HTR2A—gonad—alcohol dependence	0.000131	0.0045	CbGeAlD
Duloxetine—CYP1A2—endocrine gland—alcohol dependence	0.000126	0.00435	CbGeAlD
Duloxetine—HTR2A—digestive system—alcohol dependence	0.00012	0.00412	CbGeAlD
Duloxetine—SLC6A2—brain—alcohol dependence	0.000118	0.00405	CbGeAlD
Duloxetine—CYP1A2—liver—alcohol dependence	0.000114	0.00392	CbGeAlD
Duloxetine—HTR2A—blood—alcohol dependence	0.000114	0.00392	CbGeAlD
Duloxetine—HTR2A—midbrain—alcohol dependence	0.000112	0.00387	CbGeAlD
Duloxetine—CYP2D6—digestive system—alcohol dependence	0.000109	0.00375	CbGeAlD
Duloxetine—CYP2D6—blood—alcohol dependence	0.000104	0.00357	CbGeAlD
Duloxetine—Atomoxetine—HTR2A—alcohol dependence	0.000103	0.0697	CrCbGaD
Duloxetine—HTR2A—endocrine gland—alcohol dependence	9.88e-05	0.0034	CbGeAlD
Duloxetine—HTR2A—testis—alcohol dependence	9.42e-05	0.00324	CbGeAlD
Duloxetine—HTR2A—nervous system—alcohol dependence	9.25e-05	0.00318	CbGeAlD
Duloxetine—Dysgeusia—Acamprosate—alcohol dependence	9.22e-05	0.00101	CcSEcCtD
Duloxetine—Chills—Naltrexone—alcohol dependence	9.18e-05	0.00101	CcSEcCtD
Duloxetine—Nervousness—Acamprosate—alcohol dependence	9.15e-05	0.00101	CcSEcCtD
Duloxetine—Back pain—Acamprosate—alcohol dependence	9.11e-05	0.001	CcSEcCtD
Duloxetine—Muscle spasms—Acamprosate—alcohol dependence	9.05e-05	0.000996	CcSEcCtD
Duloxetine—Face oedema—Citalopram—alcohol dependence	9.05e-05	0.000995	CcSEcCtD
Duloxetine—Alopecia—Naltrexone—alcohol dependence	9.04e-05	0.000995	CcSEcCtD
Duloxetine—CYP2D6—endocrine gland—alcohol dependence	9e-05	0.0031	CbGeAlD
Duloxetine—Mental disorder—Naltrexone—alcohol dependence	8.97e-05	0.000986	CcSEcCtD
Duloxetine—Irritability—Citalopram—alcohol dependence	8.95e-05	0.000984	CcSEcCtD
Duloxetine—Urinary retention—Citalopram—alcohol dependence	8.91e-05	0.00098	CcSEcCtD
Duloxetine—Malnutrition—Naltrexone—alcohol dependence	8.91e-05	0.00098	CcSEcCtD
Duloxetine—HTR2A—liver—alcohol dependence	8.91e-05	0.00307	CbGeAlD
Duloxetine—HTR2A—central nervous system—alcohol dependence	8.9e-05	0.00307	CbGeAlD
Duloxetine—Mood swings—Citalopram—alcohol dependence	8.88e-05	0.000977	CcSEcCtD
Duloxetine—Tremor—Acamprosate—alcohol dependence	8.82e-05	0.00097	CcSEcCtD
Duloxetine—Ataxia—Citalopram—alcohol dependence	8.81e-05	0.000969	CcSEcCtD
Duloxetine—Flatulence—Naltrexone—alcohol dependence	8.78e-05	0.000966	CcSEcCtD
Duloxetine—Tension—Naltrexone—alcohol dependence	8.74e-05	0.000962	CcSEcCtD
Duloxetine—Ill-defined disorder—Acamprosate—alcohol dependence	8.74e-05	0.000961	CcSEcCtD
Duloxetine—Dysgeusia—Naltrexone—alcohol dependence	8.72e-05	0.00096	CcSEcCtD
Duloxetine—Dehydration—Citalopram—alcohol dependence	8.72e-05	0.000959	CcSEcCtD
Duloxetine—Anaemia—Acamprosate—alcohol dependence	8.7e-05	0.000957	CcSEcCtD
Duloxetine—HTR2A—cerebellum—alcohol dependence	8.7e-05	0.003	CbGeAlD
Duloxetine—Liver function test abnormal—Citalopram—alcohol dependence	8.65e-05	0.000952	CcSEcCtD
Duloxetine—Agitation—Acamprosate—alcohol dependence	8.65e-05	0.000952	CcSEcCtD
Duloxetine—Nervousness—Naltrexone—alcohol dependence	8.65e-05	0.000952	CcSEcCtD
Duloxetine—Back pain—Naltrexone—alcohol dependence	8.62e-05	0.000948	CcSEcCtD
Duloxetine—Angioedema—Acamprosate—alcohol dependence	8.6e-05	0.000946	CcSEcCtD
Duloxetine—CYP2D6—testis—alcohol dependence	8.58e-05	0.00296	CbGeAlD
Duloxetine—Muscle spasms—Naltrexone—alcohol dependence	8.57e-05	0.000942	CcSEcCtD
Duloxetine—Orthostatic hypotension—Citalopram—alcohol dependence	8.56e-05	0.000942	CcSEcCtD
Duloxetine—Abdominal pain upper—Citalopram—alcohol dependence	8.56e-05	0.000942	CcSEcCtD
Duloxetine—Malaise—Acamprosate—alcohol dependence	8.49e-05	0.000934	CcSEcCtD
Duloxetine—Breast disorder—Citalopram—alcohol dependence	8.47e-05	0.000932	CcSEcCtD
Duloxetine—Vertigo—Acamprosate—alcohol dependence	8.46e-05	0.000931	CcSEcCtD
Duloxetine—Syncope—Acamprosate—alcohol dependence	8.44e-05	0.000929	CcSEcCtD
Duloxetine—Cramp muscle—Citalopram—alcohol dependence	8.44e-05	0.000928	CcSEcCtD
Duloxetine—Aspartate aminotransferase increased—Citalopram—alcohol dependence	8.44e-05	0.000928	CcSEcCtD
Duloxetine—Leukopenia—Acamprosate—alcohol dependence	8.43e-05	0.000927	CcSEcCtD
Duloxetine—CYP2D6—nervous system—alcohol dependence	8.42e-05	0.0029	CbGeAlD
Duloxetine—Vision blurred—Naltrexone—alcohol dependence	8.4e-05	0.000924	CcSEcCtD
Duloxetine—Nasopharyngitis—Citalopram—alcohol dependence	8.38e-05	0.000922	CcSEcCtD
Duloxetine—Tremor—Naltrexone—alcohol dependence	8.35e-05	0.000918	CcSEcCtD
Duloxetine—Palpitations—Acamprosate—alcohol dependence	8.32e-05	0.000915	CcSEcCtD
Duloxetine—Gastritis—Citalopram—alcohol dependence	8.3e-05	0.000912	CcSEcCtD
Duloxetine—Loss of consciousness—Acamprosate—alcohol dependence	8.28e-05	0.00091	CcSEcCtD
Duloxetine—Alanine aminotransferase increased—Citalopram—alcohol dependence	8.27e-05	0.000909	CcSEcCtD
Duloxetine—Muscular weakness—Citalopram—alcohol dependence	8.27e-05	0.000909	CcSEcCtD
Duloxetine—Ill-defined disorder—Naltrexone—alcohol dependence	8.27e-05	0.000909	CcSEcCtD
Duloxetine—Cough—Acamprosate—alcohol dependence	8.22e-05	0.000904	CcSEcCtD
Duloxetine—Agitation—Naltrexone—alcohol dependence	8.19e-05	0.000901	CcSEcCtD
Duloxetine—Convulsion—Acamprosate—alcohol dependence	8.16e-05	0.000897	CcSEcCtD
Duloxetine—Angioedema—Naltrexone—alcohol dependence	8.14e-05	0.000895	CcSEcCtD
Duloxetine—Hypertension—Acamprosate—alcohol dependence	8.13e-05	0.000894	CcSEcCtD
Duloxetine—CYP2D6—liver—alcohol dependence	8.11e-05	0.00279	CbGeAlD
Duloxetine—CYP2D6—central nervous system—alcohol dependence	8.11e-05	0.00279	CbGeAlD
Duloxetine—Influenza—Citalopram—alcohol dependence	8.1e-05	0.000891	CcSEcCtD
Duloxetine—Dysphagia—Citalopram—alcohol dependence	8.1e-05	0.000891	CcSEcCtD
Duloxetine—Malaise—Naltrexone—alcohol dependence	8.03e-05	0.000884	CcSEcCtD
Duloxetine—Arthralgia—Acamprosate—alcohol dependence	8.02e-05	0.000882	CcSEcCtD
Duloxetine—Myalgia—Acamprosate—alcohol dependence	8.02e-05	0.000882	CcSEcCtD
Duloxetine—Chest pain—Acamprosate—alcohol dependence	8.02e-05	0.000882	CcSEcCtD
Duloxetine—Syncope—Naltrexone—alcohol dependence	7.99e-05	0.000879	CcSEcCtD
Duloxetine—Anxiety—Acamprosate—alcohol dependence	7.99e-05	0.000879	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	7.96e-05	0.000876	CcSEcCtD
Duloxetine—Pancreatitis—Citalopram—alcohol dependence	7.94e-05	0.000874	CcSEcCtD
Duloxetine—CYP2D6—cerebellum—alcohol dependence	7.93e-05	0.00273	CbGeAlD
Duloxetine—Discomfort—Acamprosate—alcohol dependence	7.92e-05	0.000871	CcSEcCtD
Duloxetine—Sweating increased—Citalopram—alcohol dependence	7.89e-05	0.000868	CcSEcCtD
Duloxetine—Palpitations—Naltrexone—alcohol dependence	7.87e-05	0.000866	CcSEcCtD
Duloxetine—Dry mouth—Acamprosate—alcohol dependence	7.84e-05	0.000862	CcSEcCtD
Duloxetine—Loss of consciousness—Naltrexone—alcohol dependence	7.83e-05	0.000861	CcSEcCtD
Duloxetine—Cough—Naltrexone—alcohol dependence	7.77e-05	0.000855	CcSEcCtD
Duloxetine—Abdominal discomfort—Citalopram—alcohol dependence	7.77e-05	0.000854	CcSEcCtD
Duloxetine—Confusional state—Acamprosate—alcohol dependence	7.75e-05	0.000852	CcSEcCtD
Duloxetine—Convulsion—Naltrexone—alcohol dependence	7.72e-05	0.000849	CcSEcCtD
Duloxetine—Hypertension—Naltrexone—alcohol dependence	7.69e-05	0.000846	CcSEcCtD
Duloxetine—Anaphylactic shock—Acamprosate—alcohol dependence	7.68e-05	0.000845	CcSEcCtD
Duloxetine—Infection—Acamprosate—alcohol dependence	7.63e-05	0.00084	CcSEcCtD
Duloxetine—Chest pain—Naltrexone—alcohol dependence	7.58e-05	0.000834	CcSEcCtD
Duloxetine—Arthralgia—Naltrexone—alcohol dependence	7.58e-05	0.000834	CcSEcCtD
Duloxetine—Myalgia—Naltrexone—alcohol dependence	7.58e-05	0.000834	CcSEcCtD
Duloxetine—Dysuria—Citalopram—alcohol dependence	7.58e-05	0.000833	CcSEcCtD
Duloxetine—Shock—Acamprosate—alcohol dependence	7.56e-05	0.000832	CcSEcCtD
Duloxetine—Anxiety—Naltrexone—alcohol dependence	7.56e-05	0.000831	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	7.53e-05	0.000829	CcSEcCtD
Duloxetine—Upper respiratory tract infection—Citalopram—alcohol dependence	7.53e-05	0.000828	CcSEcCtD
Duloxetine—Thrombocytopenia—Acamprosate—alcohol dependence	7.52e-05	0.000828	CcSEcCtD
Duloxetine—Tachycardia—Acamprosate—alcohol dependence	7.5e-05	0.000825	CcSEcCtD
Duloxetine—Discomfort—Naltrexone—alcohol dependence	7.49e-05	0.000824	CcSEcCtD
Duloxetine—Pollakiuria—Citalopram—alcohol dependence	7.48e-05	0.000823	CcSEcCtD
Duloxetine—Skin disorder—Acamprosate—alcohol dependence	7.46e-05	0.000821	CcSEcCtD
Duloxetine—Erectile dysfunction—Citalopram—alcohol dependence	7.46e-05	0.000821	CcSEcCtD
Duloxetine—Hyperhidrosis—Acamprosate—alcohol dependence	7.43e-05	0.000817	CcSEcCtD
Duloxetine—Dry mouth—Naltrexone—alcohol dependence	7.42e-05	0.000816	CcSEcCtD
Duloxetine—Photosensitivity reaction—Citalopram—alcohol dependence	7.39e-05	0.000813	CcSEcCtD
Duloxetine—Weight increased—Citalopram—alcohol dependence	7.37e-05	0.000811	CcSEcCtD
Duloxetine—Confusional state—Naltrexone—alcohol dependence	7.33e-05	0.000806	CcSEcCtD
Duloxetine—Weight decreased—Citalopram—alcohol dependence	7.33e-05	0.000806	CcSEcCtD
Duloxetine—Anorexia—Acamprosate—alcohol dependence	7.33e-05	0.000806	CcSEcCtD
Duloxetine—Hyperglycaemia—Citalopram—alcohol dependence	7.31e-05	0.000804	CcSEcCtD
Duloxetine—Anaphylactic shock—Naltrexone—alcohol dependence	7.27e-05	0.0008	CcSEcCtD
Duloxetine—Oedema—Naltrexone—alcohol dependence	7.27e-05	0.0008	CcSEcCtD
Duloxetine—Infection—Naltrexone—alcohol dependence	7.22e-05	0.000795	CcSEcCtD
Duloxetine—Infestation NOS—Citalopram—alcohol dependence	7.22e-05	0.000795	CcSEcCtD
Duloxetine—Infestation—Citalopram—alcohol dependence	7.22e-05	0.000795	CcSEcCtD
Duloxetine—Stevens-Johnson syndrome—Citalopram—alcohol dependence	7.16e-05	0.000788	CcSEcCtD
Duloxetine—Shock—Naltrexone—alcohol dependence	7.15e-05	0.000787	CcSEcCtD
Duloxetine—Nervous system disorder—Naltrexone—alcohol dependence	7.13e-05	0.000784	CcSEcCtD
Duloxetine—Acute coronary syndrome—Citalopram—alcohol dependence	7.12e-05	0.000783	CcSEcCtD
Duloxetine—Tachycardia—Naltrexone—alcohol dependence	7.1e-05	0.000781	CcSEcCtD
Duloxetine—Myocardial infarction—Citalopram—alcohol dependence	7.08e-05	0.000779	CcSEcCtD
Duloxetine—HTR2A—brain—alcohol dependence	7.07e-05	0.00243	CbGeAlD
Duloxetine—Skin disorder—Naltrexone—alcohol dependence	7.06e-05	0.000777	CcSEcCtD
Duloxetine—Jaundice—Citalopram—alcohol dependence	7.04e-05	0.000774	CcSEcCtD
Duloxetine—Stomatitis—Citalopram—alcohol dependence	7.04e-05	0.000774	CcSEcCtD
Duloxetine—Hyperhidrosis—Naltrexone—alcohol dependence	7.03e-05	0.000773	CcSEcCtD
Duloxetine—Conjunctivitis—Citalopram—alcohol dependence	7.02e-05	0.000772	CcSEcCtD
Duloxetine—Urinary tract infection—Citalopram—alcohol dependence	7.02e-05	0.000772	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Acamprosate—alcohol dependence	7e-05	0.00077	CcSEcCtD
Duloxetine—Insomnia—Acamprosate—alcohol dependence	6.95e-05	0.000765	CcSEcCtD
Duloxetine—Anorexia—Naltrexone—alcohol dependence	6.93e-05	0.000762	CcSEcCtD
Duloxetine—Paraesthesia—Acamprosate—alcohol dependence	6.9e-05	0.000759	CcSEcCtD
Duloxetine—Somnolence—Acamprosate—alcohol dependence	6.83e-05	0.000751	CcSEcCtD
Duloxetine—Hepatobiliary disease—Citalopram—alcohol dependence	6.83e-05	0.000751	CcSEcCtD
Duloxetine—Epistaxis—Citalopram—alcohol dependence	6.81e-05	0.000749	CcSEcCtD
Duloxetine—Dyspepsia—Acamprosate—alcohol dependence	6.76e-05	0.000744	CcSEcCtD
Duloxetine—Decreased appetite—Acamprosate—alcohol dependence	6.68e-05	0.000735	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Acamprosate—alcohol dependence	6.63e-05	0.00073	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Naltrexone—alcohol dependence	6.62e-05	0.000729	CcSEcCtD
Duloxetine—Insomnia—Naltrexone—alcohol dependence	6.58e-05	0.000723	CcSEcCtD
Duloxetine—Constipation—Acamprosate—alcohol dependence	6.57e-05	0.000723	CcSEcCtD
Duloxetine—Pain—Acamprosate—alcohol dependence	6.57e-05	0.000723	CcSEcCtD
Duloxetine—Paraesthesia—Naltrexone—alcohol dependence	6.53e-05	0.000718	CcSEcCtD
Duloxetine—Haemoglobin—Citalopram—alcohol dependence	6.52e-05	0.000717	CcSEcCtD
Duloxetine—Haemorrhage—Citalopram—alcohol dependence	6.48e-05	0.000713	CcSEcCtD
Duloxetine—Hepatitis—Citalopram—alcohol dependence	6.48e-05	0.000713	CcSEcCtD
Duloxetine—Somnolence—Naltrexone—alcohol dependence	6.46e-05	0.000711	CcSEcCtD
Duloxetine—Hypoaesthesia—Citalopram—alcohol dependence	6.45e-05	0.00071	CcSEcCtD
Duloxetine—Hallucination—Citalopram—alcohol dependence	6.45e-05	0.00071	CcSEcCtD
Duloxetine—CYP2D6—brain—alcohol dependence	6.44e-05	0.00222	CbGeAlD
Duloxetine—Pharyngitis—Citalopram—alcohol dependence	6.44e-05	0.000708	CcSEcCtD
Duloxetine—Urinary tract disorder—Citalopram—alcohol dependence	6.4e-05	0.000704	CcSEcCtD
Duloxetine—Oedema peripheral—Citalopram—alcohol dependence	6.39e-05	0.000703	CcSEcCtD
Duloxetine—Connective tissue disorder—Citalopram—alcohol dependence	6.37e-05	0.000701	CcSEcCtD
Duloxetine—Urethral disorder—Citalopram—alcohol dependence	6.36e-05	0.000699	CcSEcCtD
Duloxetine—Feeling abnormal—Acamprosate—alcohol dependence	6.33e-05	0.000697	CcSEcCtD
Duloxetine—Decreased appetite—Naltrexone—alcohol dependence	6.32e-05	0.000695	CcSEcCtD
Duloxetine—Gastrointestinal pain—Acamprosate—alcohol dependence	6.28e-05	0.000691	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Naltrexone—alcohol dependence	6.28e-05	0.00069	CcSEcCtD
Duloxetine—Fatigue—Naltrexone—alcohol dependence	6.27e-05	0.00069	CcSEcCtD
Duloxetine—Visual impairment—Citalopram—alcohol dependence	6.25e-05	0.000687	CcSEcCtD
Duloxetine—Pain—Naltrexone—alcohol dependence	6.22e-05	0.000684	CcSEcCtD
Duloxetine—Constipation—Naltrexone—alcohol dependence	6.22e-05	0.000684	CcSEcCtD
Duloxetine—Erythema multiforme—Citalopram—alcohol dependence	6.13e-05	0.000674	CcSEcCtD
Duloxetine—Urticaria—Acamprosate—alcohol dependence	6.1e-05	0.000672	CcSEcCtD
Duloxetine—Abdominal pain—Acamprosate—alcohol dependence	6.07e-05	0.000668	CcSEcCtD
Duloxetine—Body temperature increased—Acamprosate—alcohol dependence	6.07e-05	0.000668	CcSEcCtD
Duloxetine—Eye disorder—Citalopram—alcohol dependence	6.06e-05	0.000667	CcSEcCtD
Duloxetine—Tinnitus—Citalopram—alcohol dependence	6.05e-05	0.000665	CcSEcCtD
Duloxetine—Flushing—Citalopram—alcohol dependence	6.02e-05	0.000662	CcSEcCtD
Duloxetine—Cardiac disorder—Citalopram—alcohol dependence	6.02e-05	0.000662	CcSEcCtD
Duloxetine—Feeling abnormal—Naltrexone—alcohol dependence	5.99e-05	0.000659	CcSEcCtD
Duloxetine—Gastrointestinal pain—Naltrexone—alcohol dependence	5.95e-05	0.000654	CcSEcCtD
Duloxetine—Angiopathy—Citalopram—alcohol dependence	5.88e-05	0.000647	CcSEcCtD
Duloxetine—Immune system disorder—Citalopram—alcohol dependence	5.86e-05	0.000644	CcSEcCtD
Duloxetine—Mediastinal disorder—Citalopram—alcohol dependence	5.84e-05	0.000643	CcSEcCtD
Duloxetine—Chills—Citalopram—alcohol dependence	5.82e-05	0.00064	CcSEcCtD
Duloxetine—Arrhythmia—Citalopram—alcohol dependence	5.79e-05	0.000637	CcSEcCtD
Duloxetine—Urticaria—Naltrexone—alcohol dependence	5.78e-05	0.000635	CcSEcCtD
Duloxetine—Body temperature increased—Naltrexone—alcohol dependence	5.75e-05	0.000632	CcSEcCtD
Duloxetine—Abdominal pain—Naltrexone—alcohol dependence	5.75e-05	0.000632	CcSEcCtD
Duloxetine—Alopecia—Citalopram—alcohol dependence	5.73e-05	0.00063	CcSEcCtD
Duloxetine—Mental disorder—Citalopram—alcohol dependence	5.68e-05	0.000625	CcSEcCtD
Duloxetine—Hypersensitivity—Acamprosate—alcohol dependence	5.66e-05	0.000623	CcSEcCtD
Duloxetine—Malnutrition—Citalopram—alcohol dependence	5.64e-05	0.000621	CcSEcCtD
Duloxetine—Erythema—Citalopram—alcohol dependence	5.64e-05	0.000621	CcSEcCtD
Duloxetine—Flatulence—Citalopram—alcohol dependence	5.56e-05	0.000612	CcSEcCtD
Duloxetine—Tension—Citalopram—alcohol dependence	5.54e-05	0.000609	CcSEcCtD
Duloxetine—Dysgeusia—Citalopram—alcohol dependence	5.53e-05	0.000608	CcSEcCtD
Duloxetine—Asthenia—Acamprosate—alcohol dependence	5.51e-05	0.000606	CcSEcCtD
Duloxetine—Nervousness—Citalopram—alcohol dependence	5.48e-05	0.000603	CcSEcCtD
Duloxetine—Back pain—Citalopram—alcohol dependence	5.46e-05	0.000601	CcSEcCtD
Duloxetine—Pruritus—Acamprosate—alcohol dependence	5.44e-05	0.000598	CcSEcCtD
Duloxetine—Muscle spasms—Citalopram—alcohol dependence	5.43e-05	0.000597	CcSEcCtD
Duloxetine—Hypersensitivity—Naltrexone—alcohol dependence	5.36e-05	0.000589	CcSEcCtD
Duloxetine—Vision blurred—Citalopram—alcohol dependence	5.32e-05	0.000585	CcSEcCtD
Duloxetine—Tremor—Citalopram—alcohol dependence	5.29e-05	0.000582	CcSEcCtD
Duloxetine—Diarrhoea—Acamprosate—alcohol dependence	5.26e-05	0.000578	CcSEcCtD
Duloxetine—Ill-defined disorder—Citalopram—alcohol dependence	5.24e-05	0.000576	CcSEcCtD
Duloxetine—Anaemia—Citalopram—alcohol dependence	5.22e-05	0.000574	CcSEcCtD
Duloxetine—Asthenia—Naltrexone—alcohol dependence	5.22e-05	0.000574	CcSEcCtD
Duloxetine—Agitation—Citalopram—alcohol dependence	5.19e-05	0.000571	CcSEcCtD
Duloxetine—Angioedema—Citalopram—alcohol dependence	5.16e-05	0.000567	CcSEcCtD
Duloxetine—Pruritus—Naltrexone—alcohol dependence	5.14e-05	0.000566	CcSEcCtD
Duloxetine—Malaise—Citalopram—alcohol dependence	5.09e-05	0.00056	CcSEcCtD
Duloxetine—Dizziness—Acamprosate—alcohol dependence	5.08e-05	0.000559	CcSEcCtD
Duloxetine—Vertigo—Citalopram—alcohol dependence	5.07e-05	0.000558	CcSEcCtD
Duloxetine—Syncope—Citalopram—alcohol dependence	5.06e-05	0.000557	CcSEcCtD
Duloxetine—Leukopenia—Citalopram—alcohol dependence	5.05e-05	0.000556	CcSEcCtD
Duloxetine—Palpitations—Citalopram—alcohol dependence	4.99e-05	0.000549	CcSEcCtD
Duloxetine—Diarrhoea—Naltrexone—alcohol dependence	4.97e-05	0.000547	CcSEcCtD
Duloxetine—Loss of consciousness—Citalopram—alcohol dependence	4.96e-05	0.000546	CcSEcCtD
Duloxetine—Cough—Citalopram—alcohol dependence	4.93e-05	0.000542	CcSEcCtD
Duloxetine—Convulsion—Citalopram—alcohol dependence	4.89e-05	0.000538	CcSEcCtD
Duloxetine—Vomiting—Acamprosate—alcohol dependence	4.89e-05	0.000537	CcSEcCtD
Duloxetine—Hypertension—Citalopram—alcohol dependence	4.87e-05	0.000536	CcSEcCtD
Duloxetine—Rash—Acamprosate—alcohol dependence	4.85e-05	0.000533	CcSEcCtD
Duloxetine—Dermatitis—Acamprosate—alcohol dependence	4.84e-05	0.000532	CcSEcCtD
Duloxetine—Headache—Acamprosate—alcohol dependence	4.81e-05	0.00053	CcSEcCtD
Duloxetine—Dizziness—Naltrexone—alcohol dependence	4.81e-05	0.000529	CcSEcCtD
Duloxetine—Arthralgia—Citalopram—alcohol dependence	4.81e-05	0.000529	CcSEcCtD
Duloxetine—Chest pain—Citalopram—alcohol dependence	4.81e-05	0.000529	CcSEcCtD
Duloxetine—Myalgia—Citalopram—alcohol dependence	4.81e-05	0.000529	CcSEcCtD
Duloxetine—Anxiety—Citalopram—alcohol dependence	4.79e-05	0.000527	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	4.77e-05	0.000525	CcSEcCtD
Duloxetine—Discomfort—Citalopram—alcohol dependence	4.75e-05	0.000522	CcSEcCtD
Duloxetine—Dry mouth—Citalopram—alcohol dependence	4.7e-05	0.000517	CcSEcCtD
Duloxetine—Confusional state—Citalopram—alcohol dependence	4.65e-05	0.000511	CcSEcCtD
Duloxetine—Vomiting—Naltrexone—alcohol dependence	4.62e-05	0.000509	CcSEcCtD
Duloxetine—Anaphylactic shock—Citalopram—alcohol dependence	4.61e-05	0.000507	CcSEcCtD
Duloxetine—Oedema—Citalopram—alcohol dependence	4.61e-05	0.000507	CcSEcCtD
Duloxetine—Rash—Naltrexone—alcohol dependence	4.58e-05	0.000504	CcSEcCtD
Duloxetine—Dermatitis—Naltrexone—alcohol dependence	4.58e-05	0.000504	CcSEcCtD
Duloxetine—Infection—Citalopram—alcohol dependence	4.58e-05	0.000503	CcSEcCtD
Duloxetine—Nausea—Acamprosate—alcohol dependence	4.56e-05	0.000502	CcSEcCtD
Duloxetine—Headache—Naltrexone—alcohol dependence	4.55e-05	0.000501	CcSEcCtD
Duloxetine—Shock—Citalopram—alcohol dependence	4.53e-05	0.000499	CcSEcCtD
Duloxetine—Nervous system disorder—Citalopram—alcohol dependence	4.52e-05	0.000497	CcSEcCtD
Duloxetine—Thrombocytopenia—Citalopram—alcohol dependence	4.51e-05	0.000496	CcSEcCtD
Duloxetine—Tachycardia—Citalopram—alcohol dependence	4.5e-05	0.000495	CcSEcCtD
Duloxetine—Skin disorder—Citalopram—alcohol dependence	4.47e-05	0.000492	CcSEcCtD
Duloxetine—Hyperhidrosis—Citalopram—alcohol dependence	4.45e-05	0.00049	CcSEcCtD
Duloxetine—Anorexia—Citalopram—alcohol dependence	4.39e-05	0.000483	CcSEcCtD
Duloxetine—Nausea—Naltrexone—alcohol dependence	4.32e-05	0.000475	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Citalopram—alcohol dependence	4.2e-05	0.000462	CcSEcCtD
Duloxetine—Insomnia—Citalopram—alcohol dependence	4.17e-05	0.000458	CcSEcCtD
Duloxetine—Paraesthesia—Citalopram—alcohol dependence	4.14e-05	0.000455	CcSEcCtD
Duloxetine—Somnolence—Citalopram—alcohol dependence	4.1e-05	0.000451	CcSEcCtD
Duloxetine—Dyspepsia—Citalopram—alcohol dependence	4.06e-05	0.000446	CcSEcCtD
Duloxetine—Decreased appetite—Citalopram—alcohol dependence	4e-05	0.000441	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Citalopram—alcohol dependence	3.98e-05	0.000437	CcSEcCtD
Duloxetine—Fatigue—Citalopram—alcohol dependence	3.97e-05	0.000437	CcSEcCtD
Duloxetine—Pain—Citalopram—alcohol dependence	3.94e-05	0.000433	CcSEcCtD
Duloxetine—Constipation—Citalopram—alcohol dependence	3.94e-05	0.000433	CcSEcCtD
Duloxetine—Feeling abnormal—Citalopram—alcohol dependence	3.8e-05	0.000418	CcSEcCtD
Duloxetine—Gastrointestinal pain—Citalopram—alcohol dependence	3.77e-05	0.000414	CcSEcCtD
Duloxetine—Urticaria—Citalopram—alcohol dependence	3.66e-05	0.000403	CcSEcCtD
Duloxetine—Abdominal pain—Citalopram—alcohol dependence	3.64e-05	0.000401	CcSEcCtD
Duloxetine—Body temperature increased—Citalopram—alcohol dependence	3.64e-05	0.000401	CcSEcCtD
Duloxetine—Hypersensitivity—Citalopram—alcohol dependence	3.39e-05	0.000373	CcSEcCtD
Duloxetine—Asthenia—Citalopram—alcohol dependence	3.31e-05	0.000364	CcSEcCtD
Duloxetine—Pruritus—Citalopram—alcohol dependence	3.26e-05	0.000359	CcSEcCtD
Duloxetine—Diarrhoea—Citalopram—alcohol dependence	3.15e-05	0.000347	CcSEcCtD
Duloxetine—Dizziness—Citalopram—alcohol dependence	3.05e-05	0.000335	CcSEcCtD
Duloxetine—Vomiting—Citalopram—alcohol dependence	2.93e-05	0.000322	CcSEcCtD
Duloxetine—Rash—Citalopram—alcohol dependence	2.9e-05	0.00032	CcSEcCtD
Duloxetine—Dermatitis—Citalopram—alcohol dependence	2.9e-05	0.000319	CcSEcCtD
Duloxetine—Headache—Citalopram—alcohol dependence	2.89e-05	0.000317	CcSEcCtD
Duloxetine—HTR6—GPCR downstream signaling—PDYN—alcohol dependence	2.78e-05	0.000574	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	2.76e-05	0.00057	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	2.76e-05	0.00057	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—OPRK1—alcohol dependence	2.76e-05	0.000569	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CHRM2—alcohol dependence	2.75e-05	0.000568	CbGpPWpGaD
Duloxetine—Nausea—Citalopram—alcohol dependence	2.74e-05	0.000301	CcSEcCtD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	2.73e-05	0.000562	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—NPY—alcohol dependence	2.68e-05	0.000552	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—OPRD1—alcohol dependence	2.64e-05	0.000544	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	2.63e-05	0.000542	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	2.61e-05	0.000539	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CRHR1—alcohol dependence	2.59e-05	0.000533	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—HTR1B—alcohol dependence	2.58e-05	0.000533	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CRH—alcohol dependence	2.58e-05	0.000533	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—EP300—alcohol dependence	2.58e-05	0.000532	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	2.58e-05	0.000531	CbGpPWpGaD
Duloxetine—CYP1A2—Biological oxidations—ALDH2—alcohol dependence	2.54e-05	0.000524	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—OPRM1—alcohol dependence	2.53e-05	0.000521	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—PDYN—alcohol dependence	2.53e-05	0.000521	CbGpPWpGaD
Duloxetine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	2.53e-05	0.000521	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—DRD4—alcohol dependence	2.52e-05	0.00052	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—OPRK1—alcohol dependence	2.51e-05	0.000517	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	2.46e-05	0.000507	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—POMC—alcohol dependence	2.45e-05	0.000505	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CHRM2—alcohol dependence	2.43e-05	0.000502	CbGpPWpGaD
Duloxetine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	2.42e-05	0.000499	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CNR1—alcohol dependence	2.41e-05	0.000496	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—AVP—alcohol dependence	2.4e-05	0.000496	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	2.4e-05	0.000495	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	2.4e-05	0.000495	CbGpPWpGaD
Duloxetine—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	2.4e-05	0.000494	CbGpPWpGaD
Duloxetine—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	2.36e-05	0.000488	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CRHR1—alcohol dependence	2.35e-05	0.000484	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—DRD2—alcohol dependence	2.35e-05	0.000484	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—HTR7—alcohol dependence	2.35e-05	0.000484	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—NPY—alcohol dependence	2.33e-05	0.00048	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	2.33e-05	0.00048	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—OPRK1—alcohol dependence	2.32e-05	0.000478	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	2.26e-05	0.000466	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—DRD4—alcohol dependence	2.26e-05	0.000466	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—HTR1B—alcohol dependence	2.24e-05	0.000463	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CRH—alcohol dependence	2.24e-05	0.000463	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—OPRM1—alcohol dependence	2.23e-05	0.00046	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—POMC—alcohol dependence	2.22e-05	0.000458	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CHRM2—alcohol dependence	2.21e-05	0.000455	CbGpPWpGaD
Duloxetine—CYP2D6—Biological oxidations—GGT1—alcohol dependence	2.2e-05	0.000454	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CNR1—alcohol dependence	2.16e-05	0.000445	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—OPRD1—alcohol dependence	2.14e-05	0.000441	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—EP300—alcohol dependence	2.11e-05	0.000435	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—HTR7—alcohol dependence	2.1e-05	0.000434	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—DRD2—alcohol dependence	2.1e-05	0.000434	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	2.1e-05	0.000433	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	2.07e-05	0.000427	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	2.07e-05	0.000427	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	2.06e-05	0.000424	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—NPY—alcohol dependence	2.06e-05	0.000424	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—PDYN—alcohol dependence	2.05e-05	0.000423	CbGpPWpGaD
Duloxetine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	2.05e-05	0.000422	CbGpPWpGaD
Duloxetine—CYP1A2—Biological oxidations—CYP2E1—alcohol dependence	2.03e-05	0.000419	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—OPRM1—alcohol dependence	2.03e-05	0.000418	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	2.02e-05	0.000416	CbGpPWpGaD
Duloxetine—CYP1A2—Metapathway biotransformation—CYP2E1—alcohol dependence	2e-05	0.000413	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—HTR2A—alcohol dependence	2e-05	0.000413	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—HTR1B—alcohol dependence	1.98e-05	0.000409	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CRH—alcohol dependence	1.98e-05	0.000409	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—AVP—alcohol dependence	1.98e-05	0.000408	CbGpPWpGaD
Duloxetine—CYP2D6—Biological oxidations—MAOA—alcohol dependence	1.97e-05	0.000407	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—DRD4—alcohol dependence	1.96e-05	0.000404	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—OPRD1—alcohol dependence	1.94e-05	0.0004	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	1.94e-05	0.000399	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CRHR1—alcohol dependence	1.91e-05	0.000393	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CNR1—alcohol dependence	1.87e-05	0.000386	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—NPY—alcohol dependence	1.87e-05	0.000385	CbGpPWpGaD
Duloxetine—CYP1A2—Biological oxidations—GGT1—alcohol dependence	1.86e-05	0.000385	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—PDYN—alcohol dependence	1.86e-05	0.000384	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—OPRD1—alcohol dependence	1.86e-05	0.000383	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—HTR7—alcohol dependence	1.83e-05	0.000377	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—DRD2—alcohol dependence	1.83e-05	0.000377	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HTR1B—alcohol dependence	1.8e-05	0.000371	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CRH—alcohol dependence	1.8e-05	0.000371	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CHRM2—alcohol dependence	1.79e-05	0.000369	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—PDYN—alcohol dependence	1.78e-05	0.000367	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—AVP—alcohol dependence	1.77e-05	0.000365	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—DRD4—alcohol dependence	1.73e-05	0.000357	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CRHR1—alcohol dependence	1.73e-05	0.000357	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—OPRK1—alcohol dependence	1.71e-05	0.000352	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—AVP—alcohol dependence	1.7e-05	0.000351	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—OPRD1—alcohol dependence	1.69e-05	0.000348	CbGpPWpGaD
Duloxetine—CYP1A2—Biological oxidations—MAOA—alcohol dependence	1.67e-05	0.000345	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CNR1—alcohol dependence	1.65e-05	0.000341	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CRHR1—alcohol dependence	1.65e-05	0.000341	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—OPRM1—alcohol dependence	1.64e-05	0.000339	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—HTR2A—alcohol dependence	1.64e-05	0.000339	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CHRM2—alcohol dependence	1.63e-05	0.000335	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—PDYN—alcohol dependence	1.62e-05	0.000333	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—DRD2—alcohol dependence	1.61e-05	0.000333	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—HTR7—alcohol dependence	1.61e-05	0.000333	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—POMC—alcohol dependence	1.6e-05	0.00033	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—DRD4—alcohol dependence	1.57e-05	0.000325	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—OPRD1—alcohol dependence	1.56e-05	0.000321	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CHRM2—alcohol dependence	1.56e-05	0.000321	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—EP300—alcohol dependence	1.55e-05	0.00032	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	1.55e-05	0.000319	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—AVP—alcohol dependence	1.54e-05	0.000317	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—NPY—alcohol dependence	1.51e-05	0.000312	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—AVP—alcohol dependence	1.51e-05	0.000311	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CNR1—alcohol dependence	1.5e-05	0.00031	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CRHR1—alcohol dependence	1.5e-05	0.00031	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—OPRM1—alcohol dependence	1.49e-05	0.000308	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—PDYN—alcohol dependence	1.49e-05	0.000308	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—OPRK1—alcohol dependence	1.48e-05	0.000305	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—HTR2A—alcohol dependence	1.47e-05	0.000304	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—DRD2—alcohol dependence	1.47e-05	0.000302	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HTR7—alcohol dependence	1.47e-05	0.000302	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR1B—alcohol dependence	1.46e-05	0.000301	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CRH—alcohol dependence	1.46e-05	0.000301	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—OPRM1—alcohol dependence	1.43e-05	0.000294	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CHRM2—alcohol dependence	1.41e-05	0.000291	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CRHR1—alcohol dependence	1.39e-05	0.000286	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—WASF2—alcohol dependence	1.39e-05	0.000286	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ADH6—alcohol dependence	1.39e-05	0.000286	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—NPY—alcohol dependence	1.37e-05	0.000283	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—AVP—alcohol dependence	1.36e-05	0.00028	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	1.34e-05	0.000277	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—WASF1—alcohol dependence	1.33e-05	0.000274	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CRH—alcohol dependence	1.33e-05	0.000273	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HTR1B—alcohol dependence	1.33e-05	0.000273	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—NPY—alcohol dependence	1.31e-05	0.000271	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—POMC—alcohol dependence	1.31e-05	0.000271	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CHRM2—alcohol dependence	1.3e-05	0.000269	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—OPRM1—alcohol dependence	1.3e-05	0.000267	CbGpPWpGaD
Duloxetine—CYP2D6—Biological oxidations—POMC—alcohol dependence	1.28e-05	0.000265	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—DRD4—alcohol dependence	1.28e-05	0.000263	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—HTR1B—alcohol dependence	1.27e-05	0.000261	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CRH—alcohol dependence	1.27e-05	0.000261	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—AVP—alcohol dependence	1.23e-05	0.000254	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CNR1—alcohol dependence	1.22e-05	0.000251	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—OPRM1—alcohol dependence	1.2e-05	0.000247	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—NPY—alcohol dependence	1.19e-05	0.000246	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR7—alcohol dependence	1.19e-05	0.000245	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—DRD2—alcohol dependence	1.19e-05	0.000245	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—POMC—alcohol dependence	1.18e-05	0.000243	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ADH6—alcohol dependence	1.17e-05	0.000242	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—DRD4—alcohol dependence	1.16e-05	0.000239	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HTR1B—alcohol dependence	1.15e-05	0.000237	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CRH—alcohol dependence	1.15e-05	0.000237	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ADH1A—alcohol dependence	1.15e-05	0.000237	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—OPRD1—alcohol dependence	1.15e-05	0.000236	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—HTR2A—alcohol dependence	1.13e-05	0.000233	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—DRD4—alcohol dependence	1.11e-05	0.000229	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CNR1—alcohol dependence	1.11e-05	0.000228	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NPY—alcohol dependence	1.1e-05	0.000227	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PDYN—alcohol dependence	1.1e-05	0.000227	CbGpPWpGaD
Duloxetine—CYP1A2—Biological oxidations—POMC—alcohol dependence	1.09e-05	0.000224	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—DRD2—alcohol dependence	1.08e-05	0.000223	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HTR7—alcohol dependence	1.08e-05	0.000223	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR1B—alcohol dependence	1.06e-05	0.000219	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CRH—alcohol dependence	1.06e-05	0.000219	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CNR1—alcohol dependence	1.06e-05	0.000218	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—HTR7—alcohol dependence	1.03e-05	0.000213	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—DRD2—alcohol dependence	1.03e-05	0.000213	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HTR2A—alcohol dependence	1.03e-05	0.000212	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—WASF2—alcohol dependence	1.02e-05	0.000211	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CRHR1—alcohol dependence	1.02e-05	0.000211	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—POMC—alcohol dependence	1.02e-05	0.000211	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—DRD4—alcohol dependence	1.01e-05	0.000208	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—AVP—alcohol dependence	1e-05	0.000206	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—OPRD1—alcohol dependence	9.96e-06	0.000205	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—WASF1—alcohol dependence	9.8e-06	0.000202	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ADH4—alcohol dependence	9.76e-06	0.000201	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ADH1A—alcohol dependence	9.73e-06	0.000201	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CNR1—alcohol dependence	9.61e-06	0.000198	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CHRM2—alcohol dependence	9.61e-06	0.000198	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PDYN—alcohol dependence	9.55e-06	0.000197	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—DRD2—alcohol dependence	9.38e-06	0.000193	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HTR7—alcohol dependence	9.38e-06	0.000193	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—DRD4—alcohol dependence	9.3e-06	0.000192	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—AVP—alcohol dependence	9.09e-06	0.000187	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—POMC—alcohol dependence	9.03e-06	0.000186	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CNR1—alcohol dependence	8.88e-06	0.000183	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CRHR1—alcohol dependence	8.87e-06	0.000183	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—WASF2—alcohol dependence	8.87e-06	0.000183	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—OPRM1—alcohol dependence	8.82e-06	0.000182	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—EP300—alcohol dependence	8.71e-06	0.00018	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—AVP—alcohol dependence	8.69e-06	0.000179	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR7—alcohol dependence	8.66e-06	0.000179	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—DRD2—alcohol dependence	8.66e-06	0.000179	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—WASF1—alcohol dependence	8.51e-06	0.000175	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CHRM2—alcohol dependence	8.34e-06	0.000172	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR2A—alcohol dependence	8.33e-06	0.000172	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ADH7—alcohol dependence	8.3e-06	0.000171	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ADH4—alcohol dependence	8.27e-06	0.000171	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—POMC—alcohol dependence	8.2e-06	0.000169	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NPY—alcohol dependence	8.12e-06	0.000167	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GGT2—alcohol dependence	7.96e-06	0.000164	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—AVP—alcohol dependence	7.89e-06	0.000163	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR1B—alcohol dependence	7.83e-06	0.000162	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CRH—alcohol dependence	7.83e-06	0.000162	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—OPRM1—alcohol dependence	7.66e-06	0.000158	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HTR2A—alcohol dependence	7.56e-06	0.000156	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—AVP—alcohol dependence	7.29e-06	0.00015	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ADH1B—alcohol dependence	7.28e-06	0.00015	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	7.16e-06	0.000148	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NPY—alcohol dependence	7.05e-06	0.000145	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ADH7—alcohol dependence	7.03e-06	0.000145	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—DRD4—alcohol dependence	6.85e-06	0.000141	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR1B—alcohol dependence	6.8e-06	0.00014	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CRH—alcohol dependence	6.8e-06	0.00014	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GGT2—alcohol dependence	6.74e-06	0.000139	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—POMC—alcohol dependence	6.65e-06	0.000137	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CNR1—alcohol dependence	6.54e-06	0.000135	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR7—alcohol dependence	6.38e-06	0.000132	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—DRD2—alcohol dependence	6.38e-06	0.000132	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ADH1B—alcohol dependence	6.17e-06	0.000127	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR2A—alcohol dependence	6.07e-06	0.000125	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—POMC—alcohol dependence	6.04e-06	0.000125	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—MAOB—alcohol dependence	6.03e-06	0.000124	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—DRD4—alcohol dependence	5.95e-06	0.000123	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—POMC—alcohol dependence	5.78e-06	0.000119	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CNR1—alcohol dependence	5.68e-06	0.000117	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—DRD2—alcohol dependence	5.54e-06	0.000114	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR7—alcohol dependence	5.54e-06	0.000114	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—AVP—alcohol dependence	5.37e-06	0.000111	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—POMC—alcohol dependence	5.24e-06	0.000108	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ALDH2—alcohol dependence	5.13e-06	0.000106	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—MAOB—alcohol dependence	5.11e-06	0.000105	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—POMC—alcohol dependence	4.84e-06	9.99e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—AVP—alcohol dependence	4.66e-06	9.61e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR2A—alcohol dependence	4.47e-06	9.21e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GOT2—alcohol dependence	4.36e-06	8.99e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ALDH2—alcohol dependence	4.35e-06	8.96e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.18e-06	8.62e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CYP2E1—alcohol dependence	4.1e-06	8.46e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GOT1—alcohol dependence	3.76e-06	7.76e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GGT1—alcohol dependence	3.76e-06	7.76e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GOT2—alcohol dependence	3.69e-06	7.62e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—POMC—alcohol dependence	3.57e-06	7.36e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CYP2E1—alcohol dependence	3.47e-06	7.16e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—MAOA—alcohol dependence	3.37e-06	6.96e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—EP300—alcohol dependence	3.21e-06	6.63e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GOT1—alcohol dependence	3.19e-06	6.58e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GGT1—alcohol dependence	3.19e-06	6.58e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—POMC—alcohol dependence	3.1e-06	6.39e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—MAOA—alcohol dependence	2.86e-06	5.89e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.77e-06	5.72e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—EP300—alcohol dependence	2.37e-06	4.88e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—POMC—alcohol dependence	2.2e-06	4.53e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—EP300—alcohol dependence	2.06e-06	4.24e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—POMC—alcohol dependence	1.86e-06	3.84e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—EP300—alcohol dependence	1.46e-06	3e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—EP300—alcohol dependence	1.23e-06	2.55e-05	CbGpPWpGaD
